We are live on ! Find out more

738 hedge funds and large institutions have $14.9B invested in Labcorp in 2019 Q3 according to their latest regulatory filings, with 54 funds opening new positions, 268 increasing their positions, 263 reducing their positions, and 54 closing their positions.

New
Increased
Maintained
Reduced
Closed

262% more call options, than puts

Call options by funds: $86.6M | Put options by funds: $23.9M

6% more funds holding in top 10

Funds holding in top 10: 1617 (+1)

2% more repeat investments, than reductions

Existing positions increased: 268 | Existing positions reduced: 263

0.21% more ownership

Funds ownership: 105.91%106.12% (+0.21%)

0% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 54

0% less funds holding

Funds holding: 741738 (-3)

3% less capital invested

Capital invested by funds: $15.4B → $14.9B (-$509M)

Holders
738
Holders Change
-3
Holders Change %
-0.4%
% of All Funds
16.18%
Holding in Top 10
17
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+6.25%
% of All Funds
0.37%
New
54
Increased
268
Reduced
263
Closed
54
Calls
$86.6M
Puts
$23.9M
Net Calls
+$62.6M
Net Calls Change
+$33.1M
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$130M -$202K -1,387 -0.2%
Legal & General Group
27
Legal & General Group
United Kingdom
$128M +$1.38M +9,428 +1%
Allianz Asset Management
28
Allianz Asset Management
Germany
$117M -$8.1M -55,489 -6%
New York State Common Retirement Fund
29
New York State Common Retirement Fund
New York
$111M +$36.9M +252,943 +49%
TSW
30
Thompson Siegel & Walmsley
Virginia
$99.8M -$14.1M -96,561 -12%
Wellington Management Group
31
Wellington Management Group
Massachusetts
$97.9M -$3.96M -27,150 -4%
Wells Fargo
32
Wells Fargo
California
$97.1M +$6.1M +41,805 +7%
WIM
33
Weitz Investment Management
Nebraska
$94.6M -$8.36M -57,269 -8%
WRF
34
Waddell & Reed Financial
Kansas
$92.8M +$220K +1,510 +0.2%
CB
35
Cooke & Bieler
Pennsylvania
$91.8M -$548K -3,757 -0.6%
Goldman Sachs
36
Goldman Sachs
New York
$91.6M -$25.6M -175,249 -22%
Sumitomo Mitsui Trust Group
37
Sumitomo Mitsui Trust Group
Japan
$91M +$7.15M +48,969 +8%
Calamos Advisors
38
Calamos Advisors
Illinois
$89.6M -$909K -6,232 -1%
Citadel Advisors
39
Citadel Advisors
Florida
$88M -$57.6M -394,579 -39%
Jennison Associates
40
Jennison Associates
New York
$87.6M +$13.3M +91,210 +18%
Ameriprise
41
Ameriprise
Minnesota
$87M -$967K -6,627 -1%
VIM
42
Veritas Investment Management
United Kingdom
$86.3M +$3.26M +22,372 +4%
BMO
43
Beck Mack & Oliver
New York
$84.8M -$1.51M -10,349 -2%
Morgan Stanley
44
Morgan Stanley
New York
$84.3M +$22.6M +154,864 +36%
HM
45
HealthCor Management
New York
$79.5M +$80.4M +551,131 New
Bessemer Group
46
Bessemer Group
New Jersey
$77.4M -$11.6M -79,685 -13%
SAM
47
Silvercrest Asset Management
New York
$76.8M +$423K +2,897 +0.5%
Charles Schwab
48
Charles Schwab
California
$74.8M +$2.11M +14,462 +3%
Millennium Management
49
Millennium Management
New York
$73.1M -$47.5M -325,729 -39%
AQR Capital Management
50
AQR Capital Management
Connecticut
$70.1M -$72.2M -494,948 -50%

LH Hedge Fund Activity: Q3 2019 in Review

738 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Labcorp (LH) for Q3 2019, worth a combined $14.9B — down 3.3% from $15.4B a quarter earlier.

Fund positioning in LH was balanced in Q3 2019: 54 funds opened new positions, 54 closed out, 268 added to existing stakes and 263 trimmed.

The largest buyer was Melvin Capital Management, adding an estimated $212M. The largest seller was Boston Partners, cutting an estimated $134M.

  • 738 institutional investors held Labcorp (LH) as of Q3 2019, down from 741 in Q2 2019.
  • Funds reported $14.9B of Labcorp stock for Q3 2019, down 3.3% quarter-over-quarter.
  • 54 funds opened new Labcorp positions in Q3 2019 and 54 closed out, a net change of 0 holders.
  • The largest Labcorp buyer in Q3 2019 was Melvin Capital Management, an estimated $212M added.
  • The largest Labcorp seller in Q3 2019 was Boston Partners, an estimated $134M sold.

Based on aggregated 13F filings for Q3 2019.